Micron, Inc.(Head office: Chuo-ku, Tokyo, President: Michita Sato) has begun the development of AI software for analyzing imaging images of coronary arteries in patients with ischemic heart disease, in collaboration with Professor Toshiro Shinke of Division of Cardiology, Department of Medicine at Showa University School of Medicine and Focus Systems Corporation (Head office: Shinagawa-ku, Tokyo, President: Keiichi Mori). AI assessment for imaging of coronary arteries predicts the onset of myocardial infarction possible and may lead to innovations in treatment.
The Development of AI Analysis Software for Coronary Artery Imaging in Ischemic Heart Disease
Contact
Sales and Marketing Department +81-3-6262-2830
E-mail：imagingbiomarker@micron-kobe.com
Category
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.